Engineering Potent and Selective Analogues of GpTx-1, a Tarantula Venom Peptide Antagonist of the NaV1.7 Sodium Channel
Citations Over TimeTop 10% of 2015 papers
Abstract
NaV1.7 is a voltage-gated sodium ion channel implicated by human genetic evidence as a therapeutic target for the treatment of pain. Screening fractionated venom from the tarantula Grammostola porteri led to the identification of a 34-residue peptide, termed GpTx-1, with potent activity on NaV1.7 (IC50 = 10 nM) and promising selectivity against key NaV subtypes (20× and 1000× over NaV1.4 and NaV1.5, respectively). NMR structural analysis of the chemically synthesized three disulfide peptide was consistent with an inhibitory cystine knot motif. Alanine scanning of GpTx-1 revealed that residues Trp(29), Lys(31), and Phe(34) near the C-terminus are critical for potent NaV1.7 antagonist activity. Substitution of Ala for Phe at position 5 conferred 300-fold selectivity against NaV1.4. A structure-guided campaign afforded additive improvements in potency and NaV subtype selectivity, culminating in the design of [Ala5,Phe6,Leu26,Arg28]GpTx-1 with a NaV1.7 IC50 value of 1.6 nM and >1000× selectivity against NaV1.4 and NaV1.5.
Related Papers
- → The venom optimisation hypothesis: a spider injects large venom quantities only into difficult prey types(2002)133 cited
- → Quantity and quality of venom released by a spider (Cupiennius salei, Ctenidae)(1995)73 cited
- → General biochemical and immunological characteristics of the venom from Peruvian scorpion Hadruroides lunatus(2012)17 cited
- Comparison of the lethal components in Vipera aspis aspis and Vipera aspis zinnikeri venom.(1998)
- → Design, synthesis, and biological evaluation of novel diarylalkyl amides as TRPV1 antagonists(2009)13 cited